Walleye Capital
AHCO icon

Walleye Capital’s AdaptHealth AHCO Stock Holding History

Walleye Capital’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40,100
Closed -$382K – 4179
2024
Q4 		$382K Buy
+40,100
New +$406K ﹤0.01% 3212
2024
Q2 		– Sell
-2,200
Closed -$25.3K – 5529
2024
Q1 		$25.3K Buy
2,200
+1,600
+267% +$13.6K ﹤0.01% 4862
2023
Q4 		$4.37K Buy
+600
New +$4.73K ﹤0.01% 4670

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's AHCO Position: Q1 2026 in Review

Walleye Capital sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 184,966 shares — an estimated $1.84M sold.

Walleye Capital first reported a position in AHCO in Q1 2022 and held it in 6 quarters. The position peaked at $1.84M in Q4 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Walleye Capital reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 184,966 AdaptHealth shares in Q1 2026, an estimated $1.84M.
  • Walleye Capital first reported a position in AdaptHealth in Q1 2022 and held it in 6 quarters.
  • Walleye Capital's AdaptHealth position peaked at $1.84M in Q4 2025.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.